期刊
BLOOD
卷 115, 期 20, 页码 4039-4042出版社
AMER SOC HEMATOLOGY
DOI: 10.1182/blood-2009-07-231845
关键词
-
类别
资金
- NCI NIH HHS [R01 CA084198, R37 CA084198, R37-CA084198] Funding Source: Medline
- NICHD NIH HHS [R37 HD045022, R01 HD045022, R01-HD045022] Funding Source: Medline
Induced pluripotent stem cells (iPSCs) can be generated from various differentiated cell types by the expression of a set of defined transcription factors. So far, iPSCs have been generated from primary cells, but it is unclear whether human cancer cell lines can be reprogrammed. Here we describe the generation and characterization of iPSCs derived from human chronic myeloid leukemia cells. We show that, despite the presence of oncogenic mutations, these cells acquired pluripotency by the expression of 4 transcription factors and underwent differentiation into cell types derived of all 3 germ layers during teratoma formation. Interestingly, although the parental cell line was strictly dependent on continuous signaling of the BCR-ABL oncogene, also termed oncogene addiction, reprogrammed cells lost this dependency and became resistant to the BCR-ABL inhibitor imatinib. This finding indicates that the therapeutic agent imatinib targets cells in a specific epigenetic differentiated cell state, and this may contribute to its inability to fully eradicate disease in chronic myeloid leukemia patients. (Blood. 2010; 115(20): 4039-4042)
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据